top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Agents
Antiviral Agents
Autore Adamson Catherine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (386 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato Zika virus
nucleoside analogues
antiviral agents
NS5
prodrugs
ProTides
neural stem cells
RNA-dependent RNA polymerase
cytomegalovirus
latent infection
TALEN
Surveyor nuclease mutation detection assay
ie-1 gene
quantitative real-time PCR
Epstein-Barr virus
herpes viruses
lytic gene expression
Burkitt lymphoma cells
clozapine
antipsychotic drug
antiviral drug
enteroviruses
coxsackievirus B4
persistent infection
fluoxetine
resistance
mutations
herpes B virus
macacine herpesvirus-1
genistein
flavonoids
acyclovir
ganciclovir
Plantago asiatica
Clerodendrum trichotomum
RSV
therapeutic effects
acteoside
human antimicrobial peptides
antiviral strategies
defensins
cathelicidins
hepcidins
transferrins
influenza A virus
brevilin A
antiviral
sesquiterpene lactone
replication
PRRSV
polyethylenimine
PEI
virion internalization
endocytosis
HIV
pediatrics
Ethiopia
pre-treatment drug resistance
combination antiretroviral therapy (cART)
dried plasma spots
dried blood spots
sphingolipids
glycosphingolipids
viruses
lipid biosynthesis
flavivirus
Japanese encephalitis virus
furin inhibitor
precursor membrane protein
measles virus
central nervous system
tropism
treatments
porcine reproductive and respiratory syndrome virus
ginsenoside Rg1
antiviral activity
pro-inflammatory factor
NF-κB signaling pathway
acute/latent infection
congenital infection
antiviral agent
therapeutic strategies
nucleic acid-based therapeutic approach
HCMV vaccine
adoptive cell therapy
Rev response element
chemical footprinting
SHAPE
drug discovery
branched peptides
herpesvirus
immediate-early
IE1
IE2
ribozyme
RNA interference
CRISPR/Cas
small molecule
orthohantavirus
phenyl-benzotriazoles
C-FRA
Porcine circovirus type 2
epigallocatechin gallate
heparan sulfate
antiviral effect
virus attachment
microvirin
lectin
human immunodeficiency virus
hepatitis C virus
antiviral inhibitor
non-immunogenic
viral entry
protein drugs
LUMS1
oleanane-type derivatives
influenza A virus (IAV)
virus entry inhibitors
hemagglutinin (HA)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557448703321
Adamson Catherine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Family Iridoviridae Molecular and Ecological Studies of a Family Infecting Invertebrates and Ectothermic Vertebrates
Family Iridoviridae Molecular and Ecological Studies of a Family Infecting Invertebrates and Ectothermic Vertebrates
Autore Chinchar Gregory
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (234 p.)
Soggetto non controllato risk assessment
CQIV
mathematical models
amphibian
iridovirus
ISDL
Exopalaemon carinicauda
viral load
virus isolation
European chub
outbreak
Unconventional T cell
early detection
susceptible species
viral immune evasion
DNA virus
Rana grylio virus
antibody
intracellular localization
Rana grylio virus (RGV)
British Columbia
Iridoviridae
Andrias davidianus ranavirus
viral infection
susceptible-infected (SI) models
yeast two-hybrid (Y2H)
prevalence
host-pathogen interactions
Pacific herring
Procambarus clarkii
Bayesian inference
eDNA
amphibians
Artemia spp
ranavirosis
cross-species transmission
FV3
SHIV
Gryllus bimaculatus
Pacific salmon
NF-?B
cricket
IIV-6
virus binding
erythrocytic necrosis virus (ENV)
envelope protein
iridovirus core proteins
emerging infection
host
Ranavirus
white head
Rana temporaria
Imd
biosecurity
antiviral immunity
Decapodiridovirus
endemic disease
Macrobrachium rosenbergii
co-immunoprecipitation (Co-IP)
Common frog
aquatic animals
virus surveillance
immunomodulators
frog virus 3
ELISA
DIV1
megalocytivirus
Lymphocystis disease virus
bearded dragon
susceptibility
protein interaction
Pogona vitticeps
viral erythrocytic necrosis (VEN)
histopathology
epidemiology
native-fish conservation
viral transmission
Sparus aurata
immunohistochemistry
lizard
disease dynamics
immunofluorescence
transmission modelling
Macrobrachium nipponense
interferon
nonclassical MHC
heparan sulfate
ranavirus
Mexico
ISBN 3-03921-517-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367754803321
Chinchar Gregory  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Looking Forward to the Future of Heparin: New Sources, Developments and Applications
Looking Forward to the Future of Heparin: New Sources, Developments and Applications
Autore Fareed Jawed
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2018
Descrizione fisica 1 electronic resource (282 p.)
Soggetto non controllato alginate
edema
Heparin Red
solid lipid nanoparticles
Fe3O4·DA-BSA/HA
dermatan sulfate
sulfated alginate
porcine heparin
theranostics
low-molecular-weight heparin
Arixtra®
biomaterials
hepcidin
ovarian cancer
iron oxide nanoparticles
heparin-induced thrombocytopenia
bone morphogenetic protein (BMP)
hyaluronic acid (HA)
crude heparin
platelets
resistance
sclerostin
LMWH
gremlin
low molecular weight heparin (LMWH)
low molecular weight glycosaminoglycans
human plasma
single crystal X-ray structure
iron homeostasis
noggin
super paramagnetic iron oxide nanoparticles (SPION)
manufacturing methods
paclitaxel (PTX)
brain injury
bovine heparin
inflammation
qNMR
antithrombin
reference standard
quantitative NMR
enoxaparin
danaparoid sodium
NMR
GDNF
orthogonal multi-analytical methods
ternary complex
heparan sulphate
serglycin
bovine serum albumin (BSA)
HSQC
recombinant expression
heparin
heparin oligosaccharides
functional assay
BMP antagonists
intestinal lymphatic absorption
size exclusion chromatography
heparin coating
diagnosis
bioreactor
anemia
proteoglycan
heparin process
PCA
chemometric
fluorescent probe
pharmacopeia
affinity chromatography
component quantitative analysis
Fondaparinux sodium
perylene diimide dyes
thrombin inhibition
extended physicochemical characterization
cisplatin
glycosaminoglycans
TGF-?
chondroitin sulfate
dalteparin
sequence and compositional investigations
molecular weight
magnetic resonance imaging (MRI)
industrial
LC-MS
iduronic acid conformation
heparan sulfate
growth and differentiation factor (GDF)
assay
subarachnoid hemorrhage
ISBN 3-03842-950-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Looking Forward to the Future of Heparin
Record Nr. UNINA-9910346841803321
Fareed Jawed  
MDPI - Multidisciplinary Digital Publishing Institute, 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
Autore Ferroni Patrizia
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (202 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato multiple myeloma
venous thromboembolism
risk assessment models
thromboprophylaxis
direct oral anticoagulants
cancer-associated venous thromboembolism
thrombosis
pulmonary embolism
neoplasms
anticoagulants
coumarins
low molecular weight heparins
cancer
endogenous heparin
heparanase
heparan sulfate
hospice
palliative care units
low molecular weight heparin
deep vein thrombosis
cancer associated thrombosis
VTE
malignancy
direct oral anticoagulant
pancreatic cancer
low-molecular weight heparin
survival
coagulation activation
locally advanced breast cancer
prognostic model
pCR
treatment
prophylaxis
DOAC
simultaneous care
integrated care
lymphoma
Non-Hodgkin lymphoma
Hodgkin lymphoma
risk factors
molecular subtype
arterial thrombosis
ALK
ROS1
KRAS
chemotherapy
low-molecular-weight heparin (LMWH)
VKA
UFH
DOACs
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910585935803321
Ferroni Patrizia  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Role of Extracellular Matrix in Cancer Development and Progression
The Role of Extracellular Matrix in Cancer Development and Progression
Autore Tzanakakis George
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (182 p.)
Soggetto topico Research & information: general
Soggetto non controllato elastin
ribosomal protein SA
tongue carcinoma
MMP-2
EGCG
pancreatic ductal adenocarcinoma
syndecans
proteoglycans
tumor progression
angiogenesis
syndecan-4
heparan sulfate
cancer
prognosis
biomarker
signal transduction
proteoglycan
metastasis
extracellular matrix
fibrosis
immune cell modulation
neutrophils
neutrophil extracellular trap
macrophages
BCC
MMP
TIMP
invasion
lumican
cancer cell growth
motility
hyaluronan
RHAMM
CD44
wound repair
breast cancer
malignant pleural mesothelioma
pleural effusion
extracellular vesicles
biomarkers
sulfated hyaluronan
estrogen receptors
epithelial-to-mesenchymal transition
matrix metalloproteinases
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566470803321
Tzanakakis George  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui